Insulin Lispro and Pregnancy
Links shared publicly online about this topic
Halozyme Study Results Demonstrate Significantly Less Absorption Variability For Insulin Lispro Administered With PH20 Enzyme
medicalnewstoday.com — “Halozyme therapeutics, inc. (nasdaq:halo) announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analo” View full resource at medicalnewstoday.com
Most Recently Shared on November 9, 2009 at 4:55 pm By:
Halozyme Study Results Demonstrate Significantly Less Absorption Variability For Insulin Lispro Administered Wi.. http://bit.ly/ActbN
Results Of Linjeta™ Study Versus Insulin Lispro Reported In The Platform Presentation At EASD Annual Meeting
medicalnewstoday.com — “In a platform presentation at the 46th annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, investigators for Biodel Inc. (Nasdaq: BIOD) presented the results” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2010 at 3:50 pm By:
RT @mnt_diabetes Results Of Linjetaâ„¢ Study vs. Insulin Lispro Reported In The Platform Presentation at EASD Meeting http://bit.ly/cjHdmT
FDA Approves Updates To Lilly's Humalog® (insulin Lispro Injection [rDNA Origin]) Label
medicalnewstoday.com — “Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental new drug application (sNDA) with the following updates to the Humal” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 7:05 am By:
FDA Approves Updates To Lilly's Humalog® (insulin Lispro Injection [rDNA Origin]) Label http://mnt.to/3WXv #regulatory
Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
medicalnewstoday.com — “Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the” View full resource at medicalnewstoday.com
Most Recently Shared on September 3, 2010 at 1:12 pm By:
RT @mnt_diabetes Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart Wi.. http://bit.ly/arqKXo
DURABLE trial: Twice-daily insulin lispro mix improved glycemic control
endocrinetoday.com — “New data from the DURABLE trial support the concept of earlier insulin initiation. Compared with insulin glargine, patients with type 2 diabetes” View full resource at endocrinetoday.com
Most Recently Shared on March 31, 2011 at 8:59 pm By:
DURABLE trial: Twice-daily insulin lispro mix improved glycemic control http://bit.ly/gsX7R2
Humalog (insulin lispro injection [rDNA origin]) | Learn About Humalog
humalog.com — “Learn about Humalog.” View full resource at humalog.com
Most Recently Shared on May 4, 2010 at 5:22 pm By:
Diabetes drug Humalog, a mealtime insulin medication http://bit.ly/daiXtT #diabetestype2
Humalog (insulin lispro injection [rDNA origin] | How to Take Humalog
humalog.com — “Learn how to take Humalog.” View full resource at humalog.com
Most Recently Shared on May 4, 2010 at 5:23 pm By:
Humalog (insulin lispro injection [rDNA origin]) | Humalog Side Effects
humalog.com — “Learn about the most common side effects of Humalog.” View full resource at humalog.com
Most Recently Shared on May 4, 2010 at 5:24 pm By:
Are there any side effects of diabetes drug Humalog? http://bit.ly/cLSfJQ #diabetestype2
Biodel Corporation - Results of Linjeta(TM) Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
investor.biodel.com — “Biodel Corporation - Results of Linjeta(TM) Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting” View full resource at investor.biodel.com
Most Recently Shared on September 21, 2010 at 1:11 pm By:
Biodel Results of Linjeta Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Meeting: http://bit.ly/dzNg7i
Eli Lilly and Company - FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label
newsroom.lilly.com — “Eli Lilly and Company - FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label” View full resource at newsroom.lilly.com
Most Recently Shared on June 8, 2011 at 10:31 pm By:
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label http://bit.ly/jZ4a7v
Type one diabetes and pregnancy. Is the pregnancy complicated and will insulin hurt the baby?
intelihealth.com — “Type one diabetes and pregnancy. Is the pregnancy complicated and will insulin hurt the baby?” View full resource at intelihealth.com
Most Recently Shared on April 2, 2010 at 11:02 pm By:
Type one diabetes and pregnancy. Is the pregnancy complicated and will insulin hurt the baby? http://bit.ly/a3jmdc
New ET blog on insulin glargine in pregnancy
endocrinetoday.com — “New ET blog on insulin glargine in pregnancy” View full resource at endocrinetoday.com
Most Recently Shared on January 27, 2010 at 5:00 pm By:
New ET blog on insulin glargine in pregnancy http://ow.ly/10YTX
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on June 9, 2011 at 2:34 pm By:
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label: Eli… http://goo.gl/fb/HdrQt
Halozyme’s RHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable To Lispro | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Halozyme’s RHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable To Lispro | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on November 15, 2010 at 4:50 pm By:
Halozyme’s RHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable To… http://goo.gl/fb/niSDm
What Is Insulin Resistance?
medicinenet.com — “Insulin resistance is caused by obesity, pregnancy, stress, metabolic syndrome, and steroid use. It is associated with obesity, fatty liver, type 2 diabetes, heart disease, skin tags, polycystic ovary disease, and growth abnormalities.” View full resource at medicinenet.com
Most Recently Shared on January 10, 2010 at 2:29 pm By:
MedicineNet: Insulin Resistance http://bit.ly/ciBrXZ Full http://bit.ly/9VLmDL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Diabetes News
The latest diabetes news published daily. Articles from research centers, universities and prestigious journals.
-
Scott Strumello
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

